Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS‐CoV‐2 Variants: A Case Report Study with Comparison to a Vaccinated Population - Gillot, Constant; Bayart, Jean-Louis; Maloteau, Vincent; Dogné, Jean-Michel; Douxfils, Jonathan; Favresse, Julien (Case reports in infectious diseases, 2024)
Keywords: Antibodies; Case Report; Case reports; Cell culture; COVID-19 vaccines; Electronic components industry; Health aspects; Monoclonal antibodies; Patients; Pharmaceutical industry; Proteins; Severe acute respiratory syndrome coronavirus 2; Vaccination; Viral antibodies; Belgium; United States; United Kingdom; United States--US